FDA Warns Companies Selling Unlawful CBD Products

FDA Warns Companies Selling Unlawful CBD Products

The U.S. Food and Drug Administration (FDA) warns two companies for selling unlawful products labeled containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). Specifically, the warning letters address the illegal...
FDA Warns Companies Claiming to Treat Mental Health

FDA Warns Companies Claiming to Treat Mental Health

The Food and Drug Administration (FDA) warns 10 different companies selling dietary supplements claiming to treat depression and other mental health disorders with letters. These dietary supplements claim to cure, treat, mitigate or prevent depression and other mental...
Hydrolyzed Collagen in Nutraceuticals

Hydrolyzed Collagen in Nutraceuticals

The hydrolyzed collagen market, valued at USD$ 825 million in 2018, advances towards becoming a billion-dollar market by 2021, and will continue its stride at a CAGR of 8% during 2019-2029, finds a new report published by Transparency Market Research (TMR). Here, we...
FDA Inspections in 2021 Amidst COVID-19

FDA Inspections in 2021 Amidst COVID-19

Have routine FDA inspections resumed in any capacity? If not, what can industry members expect in 2021 amidst COVID-19? At the onset of the COVID-19 pandemic in 2020, FDA announced a temporary halt to on-site facility inspections. With few exceptions, the agency made...